MTPAP Gene Spastic Ataxia Type 4 Autosomal Recessive Genetic Test
Cost: AED 4400.0
Symptoms and Diagnosis
Spastic ataxia type 4 is a neurological disorder associated with the MTPAP gene. It is an autosomal recessive disorder, meaning that both copies of the gene must be mutated for an individual to develop the condition. Common symptoms of spastic ataxia type 4 include difficulty with coordination and balance, muscle stiffness, and speech difficulties.
Test Components
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre-Test Information
Before undergoing the MTPAP gene spastic ataxia type 4 genetic test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to create a pedigree chart of family members affected by spastic ataxia type 4.
Test Details
The MTPAP gene is associated with spastic ataxia type 4, an autosomal recessive disorder. Next-Generation Sequencing (NGS) genetic testing is used to analyze multiple genes simultaneously. In the case of spastic ataxia type 4, NGS genetic testing can identify mutations in the MTPAP gene that may be responsible for the condition.
The test involves obtaining a DNA sample, typically through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the MTPAP gene. The results of the test can confirm a diagnosis of spastic ataxia type 4 and provide information about the specific genetic mutation involved.
It is important to note that genetic testing for spastic ataxia type 4 should be performed in a clinical setting by a healthcare professional or genetic counselor. They can help interpret the results, provide guidance on further testing, treatment options, and family planning considerations.
| Test Name | MTPAP Gene Spastic ataxia type 4 autosomal recessive Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MTPAP Gene Spastic ataxia type 4, autosomal recessive NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MTPAP Gene Spastic ataxia type 4, autosomal recessive |
| Test Details |
The MTPAP gene is associated with spastic ataxia type 4, which is an autosomal recessive disorder. Autosomal recessive means that an individual must inherit two copies of the mutated gene, one from each parent, to develop the condition. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of spastic ataxia type 4, NGS genetic testing can be used to identify mutations in the MTPAP gene that may be responsible for the condition. The test involves obtaining a DNA sample, usually through a blood sample or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology to identify any variations or mutations in the MTPAP gene. The results of the test can help confirm a diagnosis of spastic ataxia type 4 and provide information about the specific genetic mutation involved. It is important to note that genetic testing for spastic ataxia type 4 is typically performed in a clinical setting by a healthcare professional or genetic counselor. They can help interpret the results and provide guidance on any necessary further testing, treatment options, and family planning considerations. |
